Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus
- PMID: 17492591
- DOI: 10.1086/518250
Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus
Abstract
The persistence of latently infected resting CD4+ T cells has been clearly demonstrated in human immunodeficiency virus (HIV)-infected individuals receiving effective antiviral therapy. However, estimates of the half-life of this viral reservoir have been quite divergent. We demonstrate clear evidence for decay of this HIV reservoir in patients who initiated antiviral therapy early in infection. The half-life of this latent viral reservoir was estimated to be 4.6 months. It is projected that it will take up to 7.7 years of continuous therapy to completely eliminate latently infected resting CD4+ T cells in infected individuals who initiate antiviral therapy early in HIV infection.
Comment in
-
Eliminating persistent HIV infection: getting to the end of the rainbow.J Infect Dis. 2007 Jun 15;195(12):1734-6. doi: 10.1086/518254. Epub 2007 May 2. J Infect Dis. 2007. PMID: 17492587 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials